Clopidogrel Plus Aspirin in Patients With Different Types of Single Small Subcortical Infarction

Conclusions: There was no significant difference in the efficacy of clopidogrel plus aspirin compared with aspirin alone between patients with SSSI + PAD and SSSI – PAD in the CHANCE trial. Studies in other populations and with adequate power are needed to further verify such findings.
Source: Frontiers in Neurology - Category: Neurology Source Type: research